---
document_datetime: 2023-09-21 17:07:58
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ioa-epar-all-authorised-presentations_en.pdf
document_name: ioa-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.3465933
conversion_datetime: 2025-12-22 08:16:33.40798
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
EU/1/11/689/001

EU/1/11/689/002

IOA

IOA

2.5 mg / 1.5 mg

2.5 mg / 1.5 mg

Film-coated tablet

Film-coated tablet

Oral use

Oral use blister (PVC/alu)

blister (PVC/alu)

28 tablets (24

active + 4

placebo)

3 x 28 tablets

(24 active + 4

placebo)

EU Number Invented name Strength Pharmaceutical Form Route of Administration Packaging Package size Medicinal product no longer authorised